SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Fluor Corp. – ‘10-K’ for 12/31/20 – ‘EX-10.25’

On:  Friday, 2/26/21, at 7:07am ET   ·   For:  12/31/20   ·   Accession #:  1628280-21-3360   ·   File #:  1-16129

Previous ‘10-K’:  ‘10-K/A’ on 10/14/20 for 12/31/19   ·   Next:  ‘10-K’ on 2/22/22 for 12/31/21   ·   Latest:  ‘10-K’ on 2/20/24 for 12/31/23   ·   41 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/26/21  Fluor Corp.                       10-K       12/31/20  146:24M                                    Workiva Inc Wde… FA01/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.24M 
 2: EX-10.24    Material Contract                                   HTML    140K 
 3: EX-10.25    Material Contract                                   HTML     69K 
 4: EX-10.26    Material Contract                                   HTML     65K 
 5: EX-10.27    Material Contract                                   HTML     83K 
 6: EX-10.28    Material Contract                                   HTML     87K 
 7: EX-10.29    Material Contract                                   HTML     42K 
 8: EX-10.32    Material Contract                                   HTML     54K 
 9: EX-10.48    Material Contract                                   HTML    986K 
10: EX-21.1     Subsidiaries List                                   HTML    266K 
11: EX-23.1     Consent of Expert or Counsel                        HTML     43K 
12: EX-31.1     Certification -- §302 - SOA'02                      HTML     42K 
13: EX-31.2     Certification -- §302 - SOA'02                      HTML     42K 
14: EX-32.1     Certification -- §906 - SOA'02                      HTML     39K 
15: EX-32.2     Certification -- §906 - SOA'02                      HTML     39K 
22: R1          Cover page                                          HTML    106K 
23: R2          Consolidated Statement of Operations                HTML    144K 
24: R3          Consolidated Statement of Comprehensive Income      HTML     77K 
                (Loss)                                                           
25: R4          Consolidated Balance Sheet                          HTML    154K 
26: R5          Consolidated Balance Sheet (Parenthetical)          HTML     94K 
27: R6          Consolidated Statement of Cash Flows                HTML    148K 
28: R7          Consolidated Statement of Changes in Equity         HTML    119K 
29: R8          Consolidated Statement of Changes in Equity         HTML     51K 
                (Parenthetical)                                                  
30: R9          Description of Business                             HTML     48K 
31: R10         Significant Accounting Policies                     HTML     83K 
32: R11         Recent Accounting Pronouncements Recent Accounting  HTML     52K 
                Pronouncements                                                   
33: R12         Earnings Per Share                                  HTML     69K 
34: R13         Operating Information by Segment and Geographic     HTML    154K 
                Area                                                             
35: R14         Impairment, Restructuring and Other Exit Costs      HTML     74K 
36: R15         Income Taxes                                        HTML    124K 
37: R16         Supplemental Cash Flow Information                  HTML     58K 
38: R17         Partnerships and Joint Ventures                     HTML     56K 
39: R18         Guarantees                                          HTML     42K 
40: R19         Contingencies and Commitments                       HTML     54K 
41: R20         Contract Assets and Liabilities                     HTML     58K 
42: R21         Remaining Unsatisfied Performance Obligations       HTML     58K 
43: R22         Lines of Credit, Senior Notes and Other Borrowings  HTML     55K 
44: R23         Fair Value Measurements                             HTML     95K 
45: R24         Goodwill and Intangible Assets                      HTML     63K 
46: R25         Property, Plant and Equipment                       HTML     51K 
47: R26         Stock-Based Compensation                            HTML     95K 
48: R27         Retirement Plans                                    HTML    166K 
49: R28         Other Noncurrent Liabilities                        HTML     41K 
50: R29         Leases                                              HTML    239K 
51: R30         Derivatives and Hedging                             HTML     72K 
52: R31         Other Comprehensive Income (Loss)                   HTML    196K 
53: R32         Discontinued Operations                             HTML    163K 
54: R33         Quarterly Financial Data (Unaudited)                HTML    116K 
55: R34         Significant Accounting Policies (Policies)          HTML    137K 
56: R35         Significant Accounting Policies (Tables)            HTML     53K 
57: R36         Earnings Per Share (Tables)                         HTML     67K 
58: R37         Operating Information by Segment and Geographic     HTML    148K 
                Area (Tables)                                                    
59: R38         Impairment, Restructuring and Other Exit Costs      HTML     69K 
                (Tables)                                                         
60: R39         Income Taxes (Tables)                               HTML    127K 
61: R40         Supplemental Cash Flow Information (Tables)         HTML     66K 
62: R41         Partnerships and Joint Ventures (Tables)            HTML     52K 
63: R42         Revenue from Contract with Customer (Tables)        HTML     51K 
64: R43         Remaining Unsatisfied Performance Obligations       HTML     43K 
                (Tables)                                                         
65: R44         Lines of Credit, Senior Notes and Other Borrowings  HTML     49K 
                (Tables)                                                         
66: R45         Fair Value Measurements (Tables)                    HTML     94K 
67: R46         Goodwill and Intangible Assets (Tables)             HTML     89K 
68: R47         Property, Plant and Equipment (Tables)              HTML     53K 
69: R48         Stock-Based Compensation (Tables)                   HTML     93K 
70: R49         Retirement Benefits (Tables)                        HTML    165K 
71: R50         Leases (Tables)                                     HTML    169K 
72: R51         Derivatives and Hedging (Tables)                    HTML     73K 
73: R52         Other Comprehensive Income (Loss) (Tables)          HTML    199K 
74: R53         Discontinued Operations (Tables)                    HTML    187K 
75: R54         Quarterly Financial Data (Unaudited) (Tables)       HTML    107K 
76: R55         Description of Business (Details)                   HTML     43K 
77: R56         Significant Accounting Policies - Revenue           HTML     47K 
                Recognition (Details)                                            
78: R57         Significant Accounting Policies - Schedule of       HTML     56K 
                Useful Lives (Details)                                           
79: R58         Recent Accounting Pronouncements (Details)          HTML     50K 
80: R59         Earnings Per Share (Details)                        HTML    114K 
81: R60         Earnings Per Share (Limited Duration Stockholder    HTML     55K 
                Rights Agreement) (Details)                                      
82: R61         Operating Information by Segment and Geographic     HTML    177K 
                Area - Narrative (Details)                                       
83: R62         Operating Information by Segment and Geographic     HTML    135K 
                Area - External Revenue and Segment Profit (Loss)                
                (Details)                                                        
84: R63         Operating Information by Segment and Geographic     HTML     62K 
                Area - Reconciliation to Consolidated Amounts                    
                (Details)                                                        
85: R64         Operating Information by Segment and Geographic     HTML     68K 
                Area - External Revenue and Total Assets by                      
                Geographic Area (Details)                                        
86: R65         Impairment, Restructuring and Other Exit Costs -    HTML     74K 
                Narrative (Details)                                              
87: R66         Impairment, Restructuring and Other Exit Costs -    HTML     52K 
                Restructuring Costs (Details)                                    
88: R67         Impairment, Restructuring and Other Exit Costs -    HTML     66K 
                Restructuring Liability (Details)                                
89: R68         Impairment, Restructuring and Other Exit Costs -    HTML     59K 
                Schedule of Impairment (Details)                                 
90: R69         Income Taxes - Narrative (Details)                  HTML     76K 
91: R70         Income Taxes - Income Tax Expense (Benefit)         HTML     66K 
                (Details)                                                        
92: R71         Income Taxes - U.S. Statutory Federal               HTML     68K 
                Reconciliation (Details)                                         
93: R72         Income Taxes - Deferred Tax Assets and Liabilities  HTML     73K 
                (Details)                                                        
94: R73         Income Taxes - Unrecognized Tax Benefits (Details)  HTML     50K 
95: R74         Income Taxes - U.S. and Foreign Earnings from       HTML     49K 
                Continuing Operations before Taxes (Details)                     
96: R75         Supplemental Cash Flow Information (Details)        HTML     66K 
97: R76         Partnerships and Joint Ventures - Narrative         HTML     72K 
                (Details)                                                        
98: R77         Partnerships and Joint Ventures - Summary of        HTML     83K 
                Aggregate Financial Information (Details)                        
99: R78         Partnerships and Joint Ventures - Joint Venture     HTML     52K 
                Investment Agreement (Details)                                   
100: R79         Partnerships and Joint Ventures - Variable          HTML     58K  
                Interest Entities (Details)                                      
101: R80         Guarantees (Details)                                HTML     41K  
102: R81         Contingencies and Commitments (Details)             HTML    103K  
103: R82         Contract Assets and Liabilities (Details)           HTML     51K  
104: R83         Remaining Unsatisfied Performance Obligations -     HTML     52K  
                Schedule of Remaining Performance Obligation                     
                (Details)                                                        
105: R84         Lines of Credit, Senior Notes and Other Borrowings  HTML     51K  
                - Consolidated Debt (Details)                                    
106: R85         Lines of Credit, Senior Notes and Other Borrowings  HTML    116K  
                - Narrative (Details)                                            
107: R86         Fair Value Measurements - Recurring Basis           HTML     62K  
                (Details)                                                        
108: R87         Fair Value Measurements - Financial Instruments     HTML     87K  
                Not Required to be Measured at Fair Value                        
                (Details)                                                        
109: R88         Goodwill and Intangible Assets - Narrative          HTML     58K  
                (Details)                                                        
110: R89         Goodwill and Intangible Assets - Schedule of Each   HTML     68K  
                Major Intangible Asset Class (Details)                           
111: R90         Property, Plant and Equipment (Details)             HTML     59K  
112: R91         Stock-Based Compensation - Narrative (Details)      HTML    112K  
113: R92         Stock-Based Compensation - Restricted Stock,        HTML    100K  
                Restricted Stock Unit and Stock Option Activity,                 
                Terms and Significant Assumptions for Options                    
                (Details)                                                        
114: R93         Stock-Based Compensation - Fair Value of Options    HTML     52K  
                on Grant Date (Details)                                          
115: R94         Stock-Based Compensation - Range of Exercise        HTML     74K  
                Prices and Intrinsic Value Related to Options                    
                Outstanding (Details)                                            
116: R95         Stock-Based Compensation - VDI Units Granted        HTML     49K  
                (Details)                                                        
117: R96         Retirement Plans - Defined Contribution Retirement  HTML     43K  
                Plans (Details)                                                  
118: R97         Retirement Plans - Defined Benefit Pension Plan     HTML     50K  
                Amendments and Settlement (Details)                              
119: R98         Retirement Plans - Net Periodic Pension Expense     HTML     61K  
                for Defined Benefit Pension Plans (Details)                      
120: R99         Retirement Plans - Assumptions for Determining      HTML     64K  
                Projected Benefit Obligation and Net Periodic Cost               
                of Defined Benefit Pension Plans (Details)                       
121: R100        Retirement Plans - Target and Weighted Average      HTML     63K  
                Actual Allocations and Benefit Pension Plans                     
                (Details)                                                        
122: R101        Retirement Plans - Fair Value Measurements and      HTML    110K  
                Expected Benefit Payments for Defined Benefit                    
                Pension Plans (Details)                                          
123: R102        Retirement Plans - Change in Projected Benefit      HTML    118K  
                Obligation and Plan Assets and Funded Status of                  
                Defined Benefit Pension Plans (Details)                          
124: R103        Retirement Plans - Multiemployer Pension Plans      HTML     41K  
                (Details)                                                        
125: R104        Other Noncurrent Liabilities (Details)              HTML     46K  
126: R105        Leases - Narrative (Details)                        HTML     50K  
127: R106        Leases - Components of Lease Expense (Details)      HTML     60K  
128: R107        Leases - Information Related to Right-of-Use        HTML     99K  
                Assets and Lease Liabilities (Details)                           
129: R108        Leases - Supplemental Information Related to        HTML     66K  
                Leases (Details)                                                 
130: R109        Leases - Remaining Lease Payments (Details)         HTML     87K  
131: R110        Derivatives and Hedging - Narrative (Details)       HTML     46K  
132: R111        Derivatives and Hedging - Notional Amounts and      HTML     57K  
                Fair Values (Details)                                            
133: R112        Derivatives and Hedging - Gains (Losses)            HTML     57K  
                Associated with Cash Flow Hedges (Details)                       
134: R113        Other Comprehensive Income (Loss) - Tax Effects of  HTML     74K  
                Components of Other Comprehensive Income (Loss)                  
                (Details)                                                        
135: R114        Other Comprehensive Income (Loss) - Changes in      HTML    107K  
                AOCI Balances by Component (Details)                             
136: R115        Other Comprehensive Income (Loss) - Significant     HTML     94K  
                Items Reclassified Out of AOCI (Details)                         
137: R116        Discontinued Operations - Narrative (Details)       HTML     53K  
138: R117        Discontinued Operations - Earnings From             HTML     80K  
                Discontinued Operations (Details)                                
139: R118        Discontinued Operations - Assets and Liabilities    HTML    129K  
                Held for Sale (Details)                                          
140: R119        Discontinued Operations - Consolidated Statements   HTML     55K  
                of Cash Flows for the Discontinued Operations                    
                (Details)                                                        
141: R120        Quarterly Financial Data (Unaudited) - Summary of   HTML    116K  
                Quarterly Results of Operations (Details)                        
142: R121        Quarterly Financial Data (Unaudited) - Narrative    HTML     86K  
                (Details)                                                        
144: XML         IDEA XML File -- Filing Summary                      XML    266K  
21: XML         XBRL Instance -- flr-20201231_htm                    XML   6.04M 
143: EXCEL       IDEA Workbook of Financial Reports                  XLSX    206K  
17: EX-101.CAL  XBRL Calculations -- flr-20201231_cal                XML    423K 
18: EX-101.DEF  XBRL Definitions -- flr-20201231_def                 XML   1.74M 
19: EX-101.LAB  XBRL Labels -- flr-20201231_lab                      XML   3.30M 
20: EX-101.PRE  XBRL Presentations -- flr-20201231_pre               XML   2.21M 
16: EX-101.SCH  XBRL Schema -- flr-20201231                          XSD    299K 
145: JSON        XBRL Instance as JSON Data -- MetaLinks              743±  1.12M  
146: ZIP         XBRL Zipped Folder -- 0001628280-21-003360-xbrl      Zip    962K  


‘EX-10.25’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  
Exhibit 10.25




[FDEE Consulting, Inc. Letterhead]

July 1, 2021

Carlos Hernandez
6247 Lupton Dr
Dallas, Texas 75225

Dear Carlos:


This letter will confirm the Agreement between Carlos Hernandez, (the “Consultant”), and FDEE Consulting, Inc., (the "Company").

I.     Scope of Services: The Consultant agrees to render advisory and consultation services to the Company as and when the Company may from time to time request. Each assignment will be made in writing with a description of the assignment and schedule for completion. Consulting services to be provided under this Agreement include Consultant assisting the Company in the orderly transition of Employee’s knowledge, duties, and responsibilities to others, providing advice, and cooperating with requests for assistance related to any litigation or disputes involving the Company, its subsidiaries, parents, related entities, or joint ventures, as may be requested by the Company or its legal counsel, regarding any matter, dispute or controversy of which Consultant has or may have reason to have knowledge, information, or expertise. Consultant’s cooperation in connection with such claims or actions shall include being available to meet with counsel to prepare for discovery, a hearing, or trial and to act as a witness. If Consultant is called as a witness by the Company to give testimony (oral or written) in any matter, Consultant understands that Consultant is to answer proper questions truthfully. The payment for services referenced below (which is in lieu of and shall not be duplicative of any payment for such services referenced in that certain Retirement and Release Agreement between the Consultant and Fluor Enterprises, Inc.) is not, and shall not, be contingent upon the content of the Consultant’s testimony in the course of a hearing nor shall it be contingent on the outcome of any such hearing. The Company authorizes the Executive Chairman of Fluor Corporation’s Board of Directors and its Chief Executive Officer, or their applicable designees, to approve written assignments to the Consultant hereunder.

    In performing services under this Agreement, the Consultant shall operate as and have the status of an independent contractor and shall not act as or be an agent or employee of the Company. For this reason, all of the Consultant's activities will be at his own risk, and the Consultant shall not be entitled to, and hereby waives and disclaims any right to, benefits which Company may provide to employees of Company, including but not limited to Workers' Compensation or similar benefits or other insurance protection provided by the Company. The Consultant will make his own arrangements for medical insurance and insurance coverage for the activities to be performed hereunder.

As an independent contractor, the Consultant will be solely responsible for determining the means, methods, time and place of performing the services subject to the Company's overall schedule requirements and maintaining interfaces necessary for the services and the Company will receive only the results of the Consultant's performance of the foregoing services.

II.    Term: The term of this Agreement shall begin July 1, 2021, and shall expire on June 30, 2022 unless otherwise modified by subsequent written agreement signed by Consultant and an authorized representative of the Company.
        
Exhibit A: Invoices and Expense Reimbursement- Page 1


July 1, 2021
Page 2 of 4

III.    Payment for Services: The Company shall compensate the Consultant for the actual hours worked by the Consultant for services specifically approved by the Company during the term of this agreement as follows:

(i)Fee: Consultant will be paid Five Hundred Thousand Dollars ($500,000) for the consulting services, which shall be paid out in quarterly payments, in arrears, of $125,000, gross;

(ii)The Consultant agrees services will not be provided in excess of 420 hours for the term of this agreement;

(iii)The Consultant agrees services will not be provided in excess of 125 hours per month for the term of this agreement;

(iv)Under no circumstances shall Consultant work more than 40 hours in a week.

(v)The Consultant will be reimbursed for any reasonable business expenses incurred while providing services to the Company during the term of this Agreement provided that Consultant complies with the requirements set forth in Exhibit A attached to this Agreement;

(vi)Applicable taxes including FICA (Social Security and Medicare) taxes will be withheld on all payments made to Consultant. A Form W-2 for the Consultant’s 2021 and any subsequent year's consulting compensation will be provided.

IV.    Invoicing: Within 30 days following the end of each quarter, the Consultant will furnish the Company with an invoice detailing the time devoted to the Company's service during such quarter and a description of activities performed on behalf of the Company. All invoices must present a company code, general ledger account number and a cost object. The individual responsible for approving the Consultant’s assignments must approve all invoices submitted by Consultant before Company pays the invoice. The Company shall pay such invoice within thirty (30) days of receipt and approval. The Company reserves the right to reject invoices more than 60 days past due.

V.    Inventions, Patents and Confidential Information: Consultant shall promptly disclose to the Company all discoveries, developments, improvements, inventions and other intangible rights ("Inventions") arising from performance of Consultant's services hereunder and hereby assigns said Inventions to the Company and shall execute all documents required to complete exclusive ownership by the Company or to secure patents, if deemed appropriate in the sole discretion of the Company.

VI. Confidential Information. The Consultant agrees that any information which he obtains while performing services in his consulting capacity concerning the business or operations of the Company, its affiliates or third parties with whom it conducts business (including, but not as a limitation, technical information) shall be used only to perform such services and shall not be disclosed to anyone outside the Company, except with the prior written authorization of the Company. Further, to the extent any such information is in written form, all such documents are considered company property and must be returned to the Company upon termination of this Agreement. The obligations of this paragraph shall survive any termination of this Agreement and do not apply to any information which has been publicly released or is in the public knowledge or literature.

However, nothing in this agreement prohibits or restricts Consultant from either filing charges/complaints with any governmental agency or participating in an investigation or a proceeding before any governmental agency responsible for the enforcement of any local, state or federal law. In addition,


July 1, 2021
Page 3 of 4

nothing in this agreement prohibits Consultant from: (i) reporting possible violations of federal law or regulations, including any possible securities laws violations, to any governmental agency or entity, including but not limited to, the U.S. Department of Justice, the U.S. Securities and Exchange Commission, the U.S. Congress, Occupational Health and Safety Administration, or any agency Inspector General; (ii) making any other disclosures that are protected under the whistleblower provisions of federal law or regulations; or (iii) otherwise fully participating in any whistleblower programs, including the right to receive an incentive award authorized under federal statute or regulation for information provided to the Securities & Exchange Commission or any other federal regulatory or law enforcement agency.


VII.    Supplier Expectations: The Consultant has read and understands Fluor’s Business Conduct and Ethics Expectations for Suppliers and Contractors (the Supplier Expectations) and Consultant will do nothing to violate the Supplier Expectations.

VIII.    Anti-Corruption: The Consultant will not make and has not made directly or indirectly, any payments or given anything of value to any third party, including any foreign official, foreign political party or foreign party candidate in connection with the Company's activities or in obtaining or retaining business from any government agency or instrumentality. The Consultant shall promptly notify the Company if in the course of any business for which Consultant provides or may have provided consulting services to the Company, Consultant is approached, asked or requested or offers to make any payments or giving anything of value to any third party. Additionally, Consultant agrees that during the entire term of this Agreement Consultant will not act as an agent, official, or employee of any foreign government, or foreign political party, or a candidate for foreign office, and that the fees and expenses that will be paid to Consultant under this Agreement will not be paid directly or indirectly to any such agent, official, employee, party or candidate on behalf of Company.

IX.    Corporate Assets: Consultant is expected to respect the Company's assets as he would his own. Corporate assets take many forms (land, building, equipment, etc.). Consultant is required to return any assets or related documents to Company.

X.    Compliance with Law: The Consultant agrees to fully comply with the United States Foreign Corrupt Practices Act (Public Law 95-213, 95th Congress, December 19, 1977) and all other applicable State and United States Laws. The Consultant acknowledges that Fluor Corporation and its subsidiaries require their vendors and suppliers to fully comply with the laws of the United States.

XI.    Use of Substances: The Consultant understands the Company’s goal to maintain a Drug and Alcohol free environment and agrees to fully comply with the requirements set forth in Exhibit B attached to this Agreement.

XII.    Entire Agreement: This Agreement consists of this letter and corresponding attachments Exhibits A & B referenced above. This Agreement, as defined in this paragraph, sets forth the full and complete understanding of the parties as of the date above stated, and supersedes any and all agreements and representations made or dated prior hereto with respect to the consulting services to be provided by Consultant. This Agreement can only be amended in writing and signed by the duly authorized representatives of the parties.

XIII.    Governing Law: This Agreement shall be governed by and interpreted in accordance with the laws of the State of Texas.

    Kindly indicate your agreement with the foregoing by executing the duplicate originals of this letter in the space below and returning a fully signed duplicate original to us.

                                        


July 1, 2021
Page 4 of 4



                                        FDEE CONSULTING, INC.


                                        /s/ Stacy Dillow    
    By: Stacy Dillow
     President
    

Accepted and Agreed:


/s/ Carlos M. Hernandez        10/30/2020        

By: Carlos M. Hernandez             Date:        
        







Exhibit A: Invoices and Expense Reimbursement

I.Guidelines
Consultant will be reimbursed for all pre-approved reasonable and necessary travel and other business related expenses. Reimbursed expenses must: (a) be associated with the performance of services on behalf of Company, (b) be in compliance with Internal Revenue Service regulations, federal, state and other applicable laws, and (c) not otherwise be compensated from other sources. Consultants who travel at the request of the Company must have documented approval from the Company Representative identified in the Consulting Agreement (“Company Representative”) before incurring any costs for travel for which Consultant will seek reimbursement.

Failure to comply with each of the above guidelines may result in non-reimbursement of travel and business related expenses.

II.Travel and Other Reimbursable Expenses

The following expenses are reimbursable when approved by the responsible Company Representative:

i.Air Travel
1.Coach class accommodations must be used for domestic travel in the United States.

2.Consultant is not permitted to travel internationally to perform services under this agreement.

3.Consultant should plan and ticket travel at least 14 days in advance whenever possible to take advantage of cost savings opportunities.

4.Consultant must provide a detailed itinerary for each airline ticket fee displayed on the invoice.

ii.Vehicle Rental
1.Intermediate or mid-size automobiles or smaller are authorized.

iii.Personal Automobile Travel
1.Consultants using a personal automobile for business travel on behalf of the Company will be reimbursed at the standard mileage reimbursement rate as approved by the Internal Revenue Service. The Consultant is responsible for insurance coverage. No maintenance costs of any kind or fuel charges will be reimbursed.

iv.Hotels
1.Consultants will be reimbursed for accommodations at reasonably priced hotels.
2.It is the Consultant’s responsibility to learn the hotel’s room cancellation requirements and to notify the hotel directly in time to make the cancellations.
Exhibit A: Invoices and Expense Reimbursement- Page 1



Consultant will not be reimbursed for fees that may be incurred for failure to cancel a reservation .
v.Meals
1.Meal charges must be reasonable.
2.Reimbursement for meals will only be made in conjunction with out of town travel.

Exhibit A: Invoices and Expense Reimbursement- Page 2






I.Time Charges

Fluor will pay only for the actual time necessary to complete a function. Actual time must be charged and there shall be no rounding of a time charge to the next half-hour or quarter-hour.

No reimbursement will be allowed for any time spent in complying with these requirements, nor will Consultant be compensated for any time devoted to the preparation of billing invoices.

II.Invoicing

Backup documentation or receipts for expenses in excess of $25.00 is required. Company requires that expenses be identified by date incurred and category, e.g., travel, meals, etc. Each expense item must be sufficiently detailed to enable Company to determine the exact nature, purpose, and necessity of each expense.

Within 30 days following the end of each month, the Consultant will furnish the Company with an invoice detailing the time devoted to the Company's service during such month and a description of activities performed on behalf of the Company. All invoices must present a company code, general ledger account number and a cost object. Consultant shall include expenses on the invoice.

Each invoice requires a certification that the Consultant has reviewed the invoice and believes that it accurately reports the time and expenses reasonably and necessarily incurred and directly related to the services performed under the Consulting Agreement, and, further, that the invoice complies with these Billing Requirements.

The individual responsible for approving the Consultant’s assignments must approve all invoices submitted by Consultant before Company pays the invoice. The Company shall pay such invoice within thirty (30) days of receipt and approval. The Company reserves the right to reject invoices more than 60 days past due.








Exhibit B: Drugs and Alcohol

I.Guidelines

The Company prohibits the possession, use, manufacture, distribution, dispensation or presence of drugs and alcohol on Company premises or in the performance of consulting services provided by Consultant pursuant to the Consultant Agreement and as explained in detail below.

II.Chemical Screening

The Company may request that Consultant be screened for use of drugs and/or alcohol if Consultant is suspected of being under the influence of drugs and/or alcohol due to uncharacteristic behavior, mood swings, inability to appropriately respond to questions, the odor of alcohol on the breath or person, inappropriate of aggressive behavior, etc.

III.Prohibited Conduct

Prohibited conduct may include, but is not limited to the following:

i.Possessing, using, distributing, or dispensing drugs and alcohol while performing consulting services for the Company (on or off Company property).

ii.Receiving a non-negative illicit substances screen result for drugs or alcohol.

iii.Refusing to submit to chemical screening upon request.

iv.Attempting to subvert / avoid chemical screening by means of sample substitution, adulteration or intentionally providing insufficient specimen quantity.





Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
6/30/22
7/1/21
Filed on:2/26/218-K
For Period end:12/31/2011-K,  SD
 List all Filings 


6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/20/24  Fluor Corp.                       10-K       12/31/23  117:12M                                    Workiva Inc Wde… FA01/FA
 2/21/23  Fluor Corp.                       10-K       12/31/22  122:15M                                    Workiva Inc Wde… FA01/FA
 2/22/22  Fluor Corp.                       10-K       12/31/21  137:21M                                    Workiva Inc Wde… FA01/FA
11/05/21  Fluor Corp.                       S-8        11/05/21    4:160K                                   Toppan Merrill/FA
 5/07/21  Fluor Corp.                       10-Q/A      3/31/21   93:9.9M                                   Workiva Inc Wde… FA01/FA
 5/07/21  Fluor Corp.                       10-Q        3/31/21   92:9.9M                                   Workiva Inc Wde… FA01/FA


35 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/28/20  Fluor Corp.                       8-K:1,3,9  12/22/20   12:255K                                   Toppan Merrill/FA
12/17/20  Fluor Corp.                       S-8        12/17/20    4:270K                                   Toppan Merrill/FA
12/10/20  Fluor Corp.                       10-Q        9/30/20   90:13M                                    Workiva Inc Wde… FA01/FA
 9/25/20  Fluor Corp.                       10-K       12/31/19  157:42M                                    Workiva Inc Wde… FA01/FA
 9/21/20  Fluor Corp.                       8-K:1,7,9   9/17/20   13:413K                                   Toppan Merrill/FA
 8/03/20  Fluor Corp.                       8-K:1,3,9   7/29/20   12:246K                                   Toppan Merrill/FA
 7/08/20  Fluor Corp.                       8-K:1,9     7/07/20   12:398K                                   Toppan Merrill/FA
 4/03/20  Fluor Corp.                       8-K:1,9     4/02/20   12:417K                                   Toppan Merrill/FA
 3/25/20  Fluor Corp.                       8-K:1,3,5,8 3/24/20   13:770K                                   Toppan Merrill/FA
10/31/19  Fluor Corp.                       10-Q        9/30/19   99:14M                                    Workiva Inc Wde… FA01/FA
 8/29/18  Fluor Corp.                       8-K:1,8,9   8/29/18    3:258K                                   Toppan Merrill/FA
 8/23/18  Fluor Corp.                       8-K:1,8,9   8/20/18    4:558K                                   Toppan Merrill/FA
 8/02/18  Fluor Corp.                       10-Q        6/30/18   82:9.9M                                   Toppan Merrill/FA
 5/03/18  Fluor Corp.                       10-Q        3/31/18   84:7.9M                                   Toppan Merrill/FA
11/02/17  Fluor Corp.                       10-Q        9/30/17   83:9.7M                                   Toppan Merrill/FA
 8/03/17  Fluor Corp.                       10-Q        6/30/17   83:9.6M                                   Toppan Merrill/FA
 5/04/17  Fluor Corp.                       S-8         5/04/17    4:243K                                   Toppan Merrill/FA
 2/17/17  Fluor Corp.                       10-K       12/31/16  133:21M                                    Toppan Merrill-FA
 5/05/16  Fluor Corp.                       10-Q        3/31/16   85:7.8M                                   Toppan Merrill/FA
 3/21/16  Fluor Corp.                       8-K:1,2,8,9 3/21/16    3:300K                                   Toppan Merrill/FA
 3/02/16  Fluor Corp.                       8-K:1,2,7,9 2/25/16    4:2.5M                                   Toppan Merrill/FA
 2/09/16  Fluor Corp.                       8-K:5,9     2/03/16    2:182K                                   Toppan Merrill/FA
 4/30/15  Fluor Corp.                       10-Q        3/31/15   74:9M                                     Toppan Merrill/FA
11/25/14  Fluor Corp.                       8-K:1,2,8,911/25/14    3:242K                                   Toppan Merrill/FA
 5/03/13  Fluor Corp.                       8-K:5,9     5/02/13    2:186K                                   Toppan Merrill/FA
 6/22/12  Fluor Corp.                       S-3ASR      6/22/12    6:517K                                   Toppan Merrill-FA
 5/08/12  Fluor Corp.                       8-K:5,9     5/03/12    3:205K                                   Toppan Merrill/FA
 2/22/12  Fluor Corp.                       10-K       12/31/11   89:14M                                    Toppan Merrill-FA
 9/13/11  Fluor Corp.                       8-K:1,2,9   9/13/11    2:201K                                   Toppan Merrill/FA
 9/08/11  Fluor Corp.                       8-K:8,9     9/07/11    2:578K                                   Toppan Merrill/FA
 6/29/10  Fluor Corp.                       8-K:5,9     6/23/10    3:198K                                   Toppan Merrill/FA
 2/25/09  Fluor Corp.                       10-K       12/31/08   16:2.9M                                   Toppan Merrill-FA
 2/29/08  Fluor Corp.                       10-K       12/31/07   12:1.6M                                   Toppan Merrill-FA
 3/31/03  Fluor Corp.                       10-K       12/31/02   11:1.3M                                   Bowne - Biv/FA
11/22/00  Fluor Corp.                       10-12B/A              23:1.2M                                   Donnelley … Solutions/FA
Top
Filing Submission 0001628280-21-003360   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 6:00:08.3pm ET